Addressing Inequity in Spatial Access to Lung Cancer Screening.
access
cancer screening
geospatial
health equity
health service access
lung cancer
prevention
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
31 08 2023
31 08 2023
Historique:
received:
04
08
2023
revised:
28
08
2023
accepted:
30
08
2023
medline:
28
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
The successful implementation of an equitable lung cancer screening program requires consideration of factors that influence accessibility to screening services. Using lung cancer cases in British Columbia (BC), Canada, as a proxy for a screen-eligible population, spatial access to 36 screening sites was examined using geospatial mapping and vehicle travel time from residential postal code at diagnosis to the nearest site. The impact of urbanization and Statistics Canada's Canadian Index of Multiple Deprivation were examined. Median travel time to the nearest screening site was 11.7 min (interquartile range 6.2-23.2 min). Urbanization was significantly associated with shorter drive time ( Populations at risk in rural and remote regions may face more challenges accessing screening services due to increased travel times. Drive times increased with increasing sociodemographic and economic deprivations highlighting groups that may require support to ensure equitable access to lung cancer screening.
Sections du résumé
BACKGROUND
The successful implementation of an equitable lung cancer screening program requires consideration of factors that influence accessibility to screening services.
METHODS
Using lung cancer cases in British Columbia (BC), Canada, as a proxy for a screen-eligible population, spatial access to 36 screening sites was examined using geospatial mapping and vehicle travel time from residential postal code at diagnosis to the nearest site. The impact of urbanization and Statistics Canada's Canadian Index of Multiple Deprivation were examined.
RESULTS
Median travel time to the nearest screening site was 11.7 min (interquartile range 6.2-23.2 min). Urbanization was significantly associated with shorter drive time (
CONCLUSIONS
Populations at risk in rural and remote regions may face more challenges accessing screening services due to increased travel times. Drive times increased with increasing sociodemographic and economic deprivations highlighting groups that may require support to ensure equitable access to lung cancer screening.
Identifiants
pubmed: 37754501
pii: curroncol30090586
doi: 10.3390/curroncol30090586
pmc: PMC10529474
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8078-8091Références
Soc Sci Med. 2013 Nov;97:95-103
pubmed: 24161094
Lancet Oncol. 2017 Nov;18(11):1523-1531
pubmed: 29055736
Health Rep. 2018 Feb 21;29(2):3-9
pubmed: 29465738
Int J Circumpolar Health. 2017;76(1):1324231
pubmed: 28598269
Prev Med Rep. 2017 Mar 23;6:214-220
pubmed: 28377847
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Am J Prev Med. 2019 Aug;57(2):250-255
pubmed: 31248742
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Clin Oncol (R Coll Radiol). 2010 Sep;22(7):526-32
pubmed: 20594811
BMC Palliat Care. 2014 Nov 18;13(1):49
pubmed: 25419181
Ann Intern Med. 2018 Nov 20;169(10):684-693
pubmed: 30304504
Ann Am Thorac Soc. 2021 Sep;18(9):1577-1580
pubmed: 33784236
J Natl Cancer Inst. 2021 Aug 2;113(8):1044-1052
pubmed: 33176362
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
CA Cancer J Clin. 2022 Mar;72(2):112-143
pubmed: 34878180
J Environ Public Health. 2017;2017:2819372
pubmed: 28408935
Chest. 2021 Feb;159(2):833-844
pubmed: 32888933
Cancer. 2016 Aug 1;122(15):2324-31
pubmed: 27294476
JAMA Oncol. 2017 Sep 1;3(9):1278-1281
pubmed: 28152136
Can J Public Health. 2019 Feb;110(1):62-71
pubmed: 30353502
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Health Rep. 2015 Jun;26(6):12-20
pubmed: 26086335
Respirology. 2020 Nov;25 Suppl 2:5-23
pubmed: 33200529
Ann Am Thorac Soc. 2017 Mar;14(3):403-411
pubmed: 28118039
Health Rep. 2020 Jun 17;31(3):3-13
pubmed: 32644759
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):145-151
pubmed: 27965294
J Natl Med Assoc. 2020 Apr;112(2):209-214
pubmed: 32067762
Am J Respir Crit Care Med. 2021 Aug 15;204(4):445-453
pubmed: 33823116
J Am Coll Radiol. 2019 Jan;16(1):15-23
pubmed: 30181089
Cancer Control. 2023 Jan-Dec;30:10732748221121391
pubmed: 36935556
Curr Oncol. 2015 Apr;22(2):156-63
pubmed: 25908914
Ann Oncol. 2019 Jul 1;30(7):1162-1169
pubmed: 30937431
Front Oncol. 2022 Oct 19;12:833265
pubmed: 36338766
Cancer Epidemiol. 2013 Dec;37(6):946-56
pubmed: 23702337
Lung Cancer. 2012 Sep;77(3):526-31
pubmed: 22681870
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):710-8
pubmed: 26238953
Cancer. 2022 Apr 15;128(8):1584-1594
pubmed: 35167123
J Epidemiol Community Health. 2013 Oct;67(10):861-7
pubmed: 23851149
Palliat Med. 2011 Mar;25(2):101-10
pubmed: 20937613